Small cap₹313 cr₹0.6 cr traded a dayThin: a ₹2 lakh order is 3.4% of a normal day
Close on 11 September 2026
1,043.50
−0.77%
52-week range90% of the way up
172.801,137.90
Market cap
313 cr
Revenue YoY
-98.3%
Q1 FY27
Profit YoY
-104.1%
Net margin
-29.5%
-41.5pt vs a year ago
Growth trend
-64.6pt
vs last quarter’s YoY
1 month
+4.6%
Below 52w high
8.3%
RSI (14)
45
Daily swing
4.9%
average true range
Volume
0.2×
vs 20-day average
Traded
₹1 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
Key metrics
each ranked against every stock scanned tonight
Above the 200-day average
Top of the universe
+49.0%
One-year return
Top of the universe
+467.6%
Return on capital employed
n/a
Debt to equity
n/a
Profitable quarters, last four
of the last four reported
0 of 4
Cash conversion
cash from operations against reported profit
n/a
Revenue growth, year on year
latest reported quarter
-98.3%
Below the 52-week high
distance from the highest close of the year
8.3%
How it has performed
price return over each window, beside the median NSE stock over the same days
The read
written from the numbers on this page
More of the measured facts point up than down6 supporting, 3 against, 0 worth knowing
Supporting
trading 49% above its 200-day average
sitting at 90% of its 52-week range, with little overhead supply from trapped buyers
up 468% over twelve months
matches the market's strongest stocks, which has beaten the market by +0.59 points over 20 sessions across 51,498 past signals
2 of the scans it matches have a positive measured record
3 independent kinds of evidence agree today, which is uncommon
Against
1 of the scans it matches has historically underperformed the market
revenue fell 98% year on year in the quarter ending 30 June 2026
net margin has narrowed from -2.9% to -29.5% across four quarters
Worth knowing
nothing the data supports either way
The market itself is rangebound tonight. Each scan's record is measured separately for this regime; the figure beside each chip above is the one that applies, not the all-weather number.
What would change these counts: the close crossing its 200-day average, which is 700 tonight and moves every session; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working3
Trading 49.0% above its 200-day simple average, which is the line most investors use to separate a bull phase from a bear one.
+49.0%
Up 467.6% over the past year.
+467.6%
3 different kinds of evidence point at it tonight, not 3 versions of the same one.
3 families
Needs watching4
Revenue -98.3% year on year, Rs 58 cr to Rs 1 cr.
-98.3%Rs 58 crRs 1 cr
Net profit -104.1% year on year, Rs 7 cr to Rs 0 cr.
-104.1%Rs 7 crRs 0 cr
Net margin moved from 12.1% to -29.5%.
12.1%-29.5%
Only ₹0.6 crore changes hands on a median day. A large order moves this price by itself.
₹0.6 cr
Every figure here is computed — from the company’s own filings, or from its own closing prices. The wording is generated directly from the figures.
What the scans say today
5 of 57 matched on 11 Sep
PHCAP matches 5 of the 57 scans today, across 3 different kinds of evidence (not counting 2 that match most of the market tonight). Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses. It is in the published portfolio of 3 of the 19 methods on the arena tonight.
Tonight PHCAP is in the published portfolio of 3 of the 19 methods the arena runs. Each is a rule set from a named book or paper, applied mechanically to every company we scan and published before the outcome is known. The record beside each is what that method’s earlier positions did against the market while held — the method’s history, not a forecast for this name.
“Holds for” is the method’s stated window in sessions; a name leaves its book when the rules drop it or the window runs out. Every method, its rules and its full ledger are on the arena.
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
nothing clear in the filed numbers
Going against it
revenue fell 98% against the same quarter a year earlier
profit dropped 104% year on year
net margin narrowed from -7.2% to -29.5%
revenue rose in 1 of the last 4 quarters
the company has not been profitable over the last four filed quarters
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · standalone
1
0
0
—
-29.5%
Q4 FY26
31 Mar · standalone
22
-2
-2
—
-7.2%
Q3 FY26
31 Dec · standalone
2
-2
-1
—
-81.4%
Q2 FY26
30 Sep · standalone
31
-1
-1
—
-2.9%
Q1 FY26
30 Jun · standalone
58
9
7
23.34
12.1%
Q4 FY25
31 Mar · standalone
33
-9
-7
—
-20.1%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Valuation against its own history
99 sessions since 23 April 2026
66×
median 90×
103×
now 97×
PHCAP trades at 97× trailing earnings, close to its median of 90× over this window. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
How it is priced against the universe
tonight’s multiples, ranked against every company we scan
Measure
Tonight
Where it ranks
Price to sales
trailing four quarters of revenue
5.62×
cheaper than 21% of scanned companies
Earnings yield
-1.3%
profit as a share of the market value — the P/E upside down
Quality checklist
five of Piotroski’s nine tests, the ones Indian filings support
0 of 5
✗ profitable over four quarters✗ cash conversion above 100%✗ borrowings under half of equity✗ margin up on a year ago✗ revenue up on a year ago
A low multiple is a statement about expectations, not about quality: the market usually expects less from a cheap company, and is often right. These are rankings, not fair values.
AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423) · Management filings were typically +0.06pt vs the market over the next 5 sessions (n=2,634)
Who bought size here
bulk and block deals disclosed to NSE and BSE, internal transfers removed
Over the last 40 sessions the disclosed tape in PHCAP reads Accumulated: buying dominated on 2 sessions and selling on 0, of 2 with any disclosure. Net +33,000 shares (+1.10% of the equity), ₹3.7cr at the prices dealt. The largest buyer was NINCETRENDS CAPITAL SERVICES LLP, a company,. The stock has moved -7.7% since the first of these deals.
Session by session, last 40 sessions · up and green when more shares were bought than sold, down and red when more were sold, a flat mark where nothing was disclosed
20 Jul11 Sep
Session
Side
Counterparty
Shares
Price
Value
28 Aug
Bought
NINCETRENDS CAPITAL SERVICES LLP
body corporate · BSE
17,000
1,105.09
₹1.9cr
27 Aug
Bought
INTUITIVE ALPHA INVESTMENT FUND PC
fund · BSE
16,000
1,111.00
₹1.8cr
How to read this. A bulk deal is a single trade of more than half a percent of the company’s shares; a block deal is a large trade negotiated off the order book. Both must be disclosed the same day, with the counterparty’s name. When the same name appears on both sides of the same stock on the same day it is an internal transfer and is removed before anything here is counted. Who the counterparty is comes from its name and is a guess. Across every disclosed buy on file, the stock was +0.09% against the market 20 sessions later on average, ahead of it 41% of the time, over 1,370 deals. After a disclosed sell: -1.34% against the market, ahead 41% of the time, 1,439 deals. A disclosure says what someone did, not why, and nothing here says what happens next. Full tape on the Who bought size page.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+1.7%
Versus 200-day average+49.0%
Below 52-week high8.3%
Above 52-week low+503.9%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)45.5
Higher closes in last 51 of 5
Six-month return+76.86%
Risk and liquidity
What a position costs to hold and to exit. Delivery is the share of the day’s volume taken into demat rather than squared off; trade size says whether the day’s tickets were large or small.
Typical daily swing (ATR)4.94%
What ₹1 lakh here moves on a normal dayabout ₹4,936